Clinical Trial Update: Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and safety of Cadazolid in patients with Clostridioides difficile infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Cadazolid (cadazolid)

Snippet

Sponsor: Actelion | Conditions: Clostridium Difficile Infection | Phase 1 | Status: COMPLETED